1. Home
  2. Analysis
  3. Amaryl
  4. Vectibix

Amaryl and Vectibix drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Amaryl (glimepiride) and Vectibix (panitumumab). Common drug interactions include paronychia among females and interstitial lung disease among males.

The phase IV clinical study analyzes what interactions people have when they take Amaryl and Vectibix. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Amaryl?

Amaryl has active ingredients of glimepiride. It is often used in diabetes. eHealthMe is studying from 32,259 Amaryl users. Check the latest studies of Amaryl.

What is Vectibix?

Vectibix has active ingredients of panitumumab. eHealthMe is studying from 8,945 Vectibix users. Check the latest studies of Vectibix.

On Jul, 08, 2026

12 people who take Amaryl and Vectibix together, and have interactions are studied.

Amaryl and Vectibix drug interactions.

What are the common drug interactions of Amaryl and Vectibix, by gender? *:

female:

  1. Paronychia (infection in the tissues adjacent to a nail on a finger or toe)

male:

  1. Interstitial lung disease
  2. Infusion related reaction
  3. Constipation
  4. Dermatitis acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis)
  5. Gastric ulcer (stomach ulcer)
  6. Herpes virus infection
  7. Neurosis (a class of functional mental disorders involving distress but neither delusions nor hallucinations)
  8. Pain
  9. Pruritus (severe itching of the skin)
  10. Purpura (purplish discoloration of the skin)

What are the common drug interactions of Amaryl and Vectibix, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Interstitial lung disease
  2. Infusion related reaction
  3. Dermatitis acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis)
  4. Gastric ulcer (stomach ulcer)
  5. Herpes virus infection
  6. Neurosis (a class of functional mental disorders involving distress but neither delusions nor hallucinations)
  7. Pain
  8. Pruritus (severe itching of the skin)
  9. Rash
  10. Respiratory distress (difficulty in breathing)

What are the existing conditions these people have? *

  1. Colon Cancer: 10 people, 83.33%
  2. High Blood Pressure: 6 people, 50.00%
  3. Oedema Peripheral (superficial swelling): 4 people, 33.33%
  4. Stomatitis (inflammation of mucous membrane of mouth): 4 people, 33.33%
  5. Cancer Pain: 4 people, 33.33%
  6. Constipation: 4 people, 33.33%
  7. Hepatic Function Abnormal: 4 people, 33.33%
  8. Allergies: 4 people, 33.33%
  9. Rashes (redness): 4 people, 33.33%
  10. Skin Exfoliation (removal of the oldest dead skin cells): 4 people, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Amaryl and Vectibix?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Amaryl and Vectibix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Amaryl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vectibix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Amaryl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vectibix and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on glimepiride and panitumumab (the active ingredients of Amaryl and Vectibix, respectively), and Amaryl and Vectibix (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.